Researchers identified 127 regions of DNA associated with Alzheimer’s risk across the analyses in a Nature paper. They classified 48 of those regions, known as loci, as new. The total combines 118 loci from an analysis spanning multiple ancestry groups with nine additional loci from an analysis limited to people of European ancestry. It is a count of associated regions, not 127 newly discovered genes.
The study drew on 30 cohorts, comprising 109,479 Alzheimer’s cases, 74,141 proxy cases, 2,131,799 controls and 499,708 proxy controls. Together, those groups total about 2.8 million people. Proxy cases were participants whose mother or father was reported to have Alzheimer’s or dementia; they were not counted as people with Alzheimer’s themselves.
A stronger signal in microglia
The researchers compared genetic-risk signals with patterns of gene activity in brain cell types. They found an association with genes upregulated in microglia in Alzheimer’s cases compared with controls. They also found associations with genes downregulated in three neuronal subtypes. After an additional correction for gene-activity patterns shared across cell types, the microglial association remained statistically significant, while the neuronal subtype associations were only nominally significant. The researchers suggest the latter may reflect a broader pattern of downregulated genes in neurons rather than a signal specific to those three subtypes.
The team prioritized potential targets for future drug-development research, but these genetic associations do not demonstrate that a treatment works. The paper also says it is unclear whether the neuronal pattern reflects a primary or secondary disease process. And although the analyses included several ancestry groups, 91% of the study’s effective sample was of European ancestry; the researchers say this made ancestry-specific findings and prediction in non-European samples less precise.
Comments